RheumaFinder

Vlasgaardstraat 52

9000 Gent

BE

RheumaFinder

Foundation date

11/05/2023

Sector

#Biotechnology / R&D Services

Subsector

Therapeutic areas

RheumaFinder is an imaging AI startup in Ghent.

RheumaFinder’s software is an advanced AI solution that will detect different rheumatic diseases on conventional medical imaging.

As rheuma is a very prevalent disease (> 5% world population), their solutions will help to solve the problem of underdiagnosis (up to 50%) and delayed diagnosis (up to 10 years) in rheumatic diseases. If patients with these diseases would remain undiagnosed, progressive joint destruction occurs with subsequent symptoms (pain, limited mobility), decreased quality of life due to a lifelong disease burden and high societal costs.

In summary, the value proposition is an AI based automated early detection of signs of rheumatic diseases in medical imaging for diagnosis, follow-up and early therapy management.

The solution is primarily intended for radiologists to assist them in referring a patient earlier to a rheumatologist for official diagnosis and treatment initiation.

Upcoming events

Latest news

  • V-Bio Ventures leads €20 million Series A financing of Precision oncology company Flindr Therapeutics to advance first-in-class small molecule inhibitors

    Wednesday April 24th 2024

  • Labconsort and NEKTARI join forces for a more sustainable and social industry

    Saturday April 20th 2024

  • BIO INX Complements Advisory Board with Distinguished Industry Leaders

    Thursday April 18th 2024